Preserving evidence-based access to mifepristone, including when dispensed by mail or retail pharmacy, is necessary to mitigate the imminent harm facing members of the public.
Ron Wyden: “Preserving evidence-based access to mifepristone, including when dispensed by mail or retail pharmacy, is necessary to…”
On the recordMay 26, 2026
Source
wyden.senate.govEditor's note · Context
Emphasizing the need for access to mifepristone.
Share
More from Ron Wyden
Oct 10, 2026
Flock’s AI surveillance cameras have sparked a nationwide backlash against unnecessary government intrusion into Americans’ lives.
Oct 10, 2026
Community health workers are the backbone of rural and underserved communities.
Oct 8, 2026
This throws doubt upon Treasury’s interpretation of many provisions of the Code, creates a great deal of uncertainty in the administration of our tax laws, and could balloon the deficit.
Oct 15, 2026
The Department’s recent decision in August 2026 to quietly strip explicit prohibitions against political interference from its Scientific Integrity Policy is yet another attempt by the Trump administration to undermine scientific facts and…





